ENHANCED CLEARING OF HELICOBACTER-PYLORI AFTER OMEPRAZOLE PLUS ROXITHROMYCIN TREATMENT

被引:7
作者
CELLINI, L
MARZIO, L
DIGIROLAMO, A
ALLOCATI, N
GROSSI, L
DAINELLI, B
机构
关键词
HELICOBACTER-PYLORI; OMEPRAZOLE; ROXITHROMYCIN; GASTRITIS; DUODENAL ULCER;
D O I
10.1016/0378-1097(91)90365-H
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro antibacterial activity of omeprazole against eight strains of Helicobacter pylori was evaluated. Minimum inhibitory concentration (MIC) values were 32-mu-g/ml and 64-mu-g/ml (MIC50 and MIC90 respectively). We performed a randomized single blind study comparing the efficacy of omeprazole alone (for 4 weeks) or combined with roxithromycin (for 2 weeks) in the treatment of duodenal ulcer and chronic active gastritis associated with H. pylori infection, H. pylori was eradicated in 75% of patients treated with omeprazole alone whereas the patients treated with the combination of these drugs were completely free from H. pylori at the end of the therapy.
引用
收藏
页码:255 / 257
页数:3
相关论文
共 14 条
[1]  
BIASCO G, 1989, LANCET, V2, P1403
[2]   HELICOBACTER-PYLORI AND THE PATHOGENESIS OF GASTRODUODENAL INFLAMMATION [J].
BLASER, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :626-633
[3]   SUSCEPTIBILITY OF CAMPYLOBACTER-PYLORIDIS TO 3 MACROLIDE ANTIBIOTICS (ERYTHROMYCIN, ROXITHROMYCIN [RU-28965], AND CP-62,993) AND RIFAMPIN [J].
CZINN, S ;
CARR, H ;
ARONOFF, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :328-329
[4]   LONG-TERM STORAGE OF CAMPYLOBACTER-PYLORI [J].
DRUMM, B ;
SHERMAN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (07) :1655-1656
[5]   OMEPRAZOLE - THE 1ST PROTON PUMP INHIBITOR [J].
LINDBERG, P ;
BRANDSTROM, A ;
WALLMARK, B ;
MATTSSON, H ;
RIKNER, L ;
HOFFMANN, KJ .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (01) :1-54
[6]  
MARSHALL BJ, 1988, LANCET, V2, P1437
[7]   SUSCEPTIBILITY OF CLINICAL ISOLATES OF CAMPYLOBACTER-PYLORIDIS TO 11 ANTIMICROBIAL AGENTS [J].
MCNULTY, CAM ;
DENT, J ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) :837-838
[8]   CAMPYLOBACTER PYLORIDIS AND ASSOCIATED GASTRITIS - INVESTIGATOR BLIND, PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE AND ERYTHROMYCIN ETHYLSUCCINATE [J].
MCNULTY, CAM ;
GEARTY, JC ;
CRUMP, B ;
DAVIS, M ;
DONOVAN, IA ;
MELIKIAN, V ;
LISTER, DM ;
WISE, R .
BRITISH MEDICAL JOURNAL, 1986, 293 (6548) :645-649
[9]   INHIBITORY ANTIMICROBIAL CONCENTRATIONS AGAINST CAMPYLOBACTER-PYLORI IN GASTRIC-MUCOSA [J].
MCNULTY, CAM ;
DENT, JC ;
FORD, GA ;
WILKINSON, SP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) :729-738
[10]   CHARACTERIZATION OF CAMPYLOBACTER-PYLORIDIS BY CULTURE ENZYMATIC PROFILE, AND PROTEIN-CONTENT [J].
MEGRAUD, F ;
BONNET, F ;
GARNIER, M ;
LAMOULIATTE, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (06) :1007-1010